⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,273.46USD

-33.2300 (-2.54%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on LLY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Calls on LLY

  • @VIC_BOT · Sep 2, 2026BUY

    Buy LLY at $1,179.11

    Imported from Value Investors Club — gary9

    +8.0%

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$6.67▼$9.4737
Next quarter$10.17▲$9.9364
Current year$34.59▲$34.5658
Next year$47.22▲$44.8875

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$6.58$8.38+1.80 (+27.3%)
2026-03-31$6.79$8.55+1.76 (+25.9%)
2025-12-31$6.91$7.54+0.63 (+9.1%)
2025-09-30$5.89$7.02+1.13 (+19.2%)

Wall Street coverage

459 ratings from 41 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Leerink PartnersMaintainedOutperform$1,309 $1,316Oct 21, 2026
RBC CapitalReiteratedOutperform$1,500Oct 12, 2026
Cantor FitzgeraldMaintainedOverweight$1,410 $1,440Oct 8, 2026
Morgan StanleyMaintainedOverweight$1,419 $1,430Oct 7, 2026
JP MorganMaintainedOverweight$1,400 $1,500Sep 28, 2026
TD CowenReiteratedBuy$1,250Sep 22, 2026
GuggenheimMaintainedBuy$1,273 $1,284Sep 18, 2026
HSBCMaintainedReduce$850 $940Sep 10, 2026
Truist SecuritiesMaintainedBuy$1,370 $1,376Aug 7, 2026
Wells FargoMaintainedOverweight$1,280 $1,330Aug 6, 2026
Cantor FitzgeraldMaintainedOverweight$1,350 $1,410Aug 6, 2026
CitigroupMaintainedBuy$1,500 $1,600Jul 15, 2026
BernsteinMaintainedOutperform$1,300 $1,385Jul 14, 2026
UBSMaintainedBuy$1,250 $1,425Jul 13, 2026
GuggenheimMaintainedBuy$1,235 $1,273Jul 13, 2026
B of A SecuritiesMaintainedBuy$1,251 $1,334Jul 10, 2026
Truist SecuritiesMaintainedBuy$1,281 $1,370Jul 8, 2026
Morgan StanleyMaintainedOverweight$1,344 $1,347Jul 8, 2026
RBC CapitalMaintainedOutperform$1,250 $1,500Jul 8, 2026
JP MorganMaintainedOverweight$1,300 $1,400Jul 7, 2026
Cantor FitzgeraldMaintainedOverweight$1,230 $1,350Jul 6, 2026
Leerink PartnersMaintainedOutperform$1,119 $1,232Jun 25, 2026
JefferiesMaintainedBuy$1,330 $1,350Jun 9, 2026
B of A SecuritiesMaintainedBuy$1,133 $1,251May 26, 2026
BarclaysMaintainedOverweight$1,350 $1,400May 5, 2026

Insider transactions

42 filings from 21 insiders · 28 buy / 8 sell over 6m

Officers and directors of LLY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Alvarez RalphDirectorGrant10.011$1240.34$12kOct 19, 2026
Sulzberger GabrielleDirectorGrant3.998$1240.34$5kOct 19, 2026
LUCIANO JUAN RDirectorGrant12.833$1240.34$16kOct 19, 2026
Fyrwald J ErikDirectorGrant7.995$1240.34$10kOct 19, 2026
Alvarez RalphDirectorGrant10.659$1164.89$12kSep 21, 2026
Sulzberger GabrielleDirectorGrant4.257$1164.89$5kSep 21, 2026
LUCIANO JUAN RDirectorGrant13.664$1164.89$16kSep 21, 2026
Fyrwald J ErikDirectorGrant8.513$1164.89$10kSep 21, 2026
Seymour MelissaOfficer, EVP, Global QualityGift12——Sep 9, 2026
Dozier EricOfficer, EVP, Chief People OfficerGift216——Sep 2, 2026
Hernandez EdgardoOfficer, EVP & Pres., Mfg. OperationsGift13——Sep 2, 2026
Seymour MelissaOfficer, EVP, Global QualityGift17——Sep 22, 2025
LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of SecuritySell23.7k$763.05$18.06MSep 19, 2025
LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of SecuritySell106.6k$763.29$81.53MSep 18, 2025
SULZBERGER GABRIELLEDirectorGrant6$748.19$5kSep 15, 2025
ALVAREZ RALPHDirectorGrant15$748.19$12kSep 15, 2025
HEDLEY MARY LYNNEDirectorGrant13$748.19$10kSep 15, 2025
FYRWALD J. ERIKDirectorGrant13$748.19$10kSep 15, 2025
LUCIANO JUAN RDirectorGrant19$748.19$15kSep 15, 2025
HERNANDEZ EDGARDOOfficerGift17——Sep 5, 2025

Analyst Notes

Sign in to write
  • @VIC_BOT wrote a note on LLY · Sep 2, 2026Buy

    LILLY (ELI) & CO (LLY)

    0 likes · 0 comments

Top voices on LLY

Members whose judged calls on LLY have played out most reliably.

No settled calls on LLY yet. 1 call is open, the first due Sep 2, 2027.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

30 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current620311Buy2.06
1 mo ago619311Buy2.07
2 mo ago618411Buy2.10
3 mo ago517411Buy2.14
Price target$1,331.55$930.00 – $1,600.00
+4.6% to target